News

HPV vaccination rates not improved by increased awareness


 

FROM PEDIATRICS

References

Increased awareness did not increase adolescent HPV vaccination rates in a high-risk population, according to Jessica Fishman, PhD, of the University of Pennsylvania, Philadelphia, and her associates.

The study sample included 211 low-income adolescents, aged 13-18 years, and 149 parents of different adolescents, aged 9-18 years, who had not been vaccinated for HPV. In the adolescent group, 3% received an HPV vaccination after 3 months, 9% received a vaccination after 6 months, and 15% received a vaccination after 1 year. In the parent group, 5% had their daughters vaccinated after 3 months, 10% had their daughters vaccinated after 6 months, and 13% had their daughters vaccinated after 1 year.

©jarun011/Thinkstock

Awareness was measured using a questionnaire asking about individual awareness of HPV, cervical cancer, HPV vaccination, and news or advertising about HPV vaccination. Both adolescents and parents were most aware of cervical cancer (73% and 94%, respectively) and least aware of news about HPV advertising (51% and 66%, respectively). A total of 14% of adolescents and 4% of parents had no awareness of any questionnaire item, while 32% of adolescents and 57% of parents had awareness of all items.

Probability of vaccination was less than 0.5 for all levels of awareness, and accuracy of HPV vaccination prediction models was poor, Dr. Fishman and her associates noted.

“For this high-risk population where vaccination is rare, evidence-based behavioral interventions are urgently needed. Ideally, interventions will target variables associated with vaccination. Interventions that do not target actual determinants can have no effect or even a ‘boomerang’ effect that increases unhealthy behavior,” the investigators concluded.

Find the full study in Pediatrics (doi: 10.1542/peds.2015-2048).

lfranki@frontlinemedcom.com

Recommended Reading

FDA approves first cholera vaccine for travelers
MDedge Infectious Disease
ACIP recommends MenACWY vaccine for HIV-infected persons 2 months and older
MDedge Infectious Disease
ACIP votes to scrap LAIV vaccine for 2016-2017 influenza season
MDedge Infectious Disease
ACIP hints at move from three-dose to two-dose HPV vaccination schedule for youth
MDedge Infectious Disease
Zika vaccine development to get underway
MDedge Infectious Disease
Novel vaccine scores better hepatitis B seroprotection in type 2 diabetes
MDedge Infectious Disease
Appreciate family cognitive style when discussing vaccines
MDedge Infectious Disease
Malaria vaccine disappoints in phase II trial
MDedge Infectious Disease
Incidence of HPV-associated cancers on the rise
MDedge Infectious Disease
9-valent, quadrivalent HPV vaccines have comparable safety
MDedge Infectious Disease